Method for separating hematopoietic stem cells from umbilical cord blood and amplifying CD34 positive cells
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- BOYALIFE
- Publication Date
- 2017-05-24
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The present invention belongs to the field of treating clinical diseases with cell biology techniques. Specifically, the present invention relates to a method for preparing CD34 from umbilical cord blood hematopoietic stem cells + cell method. Background technique
[0002] Stem cells mediate regeneration and the transmission of genetic information to subsequent cell generations. They can self-renew and produce differentiated progeny. In recent years, advances have been made in our understanding of the molecular mechanisms underlying the interactions between stem cells and their tissue microecological environment. This has led to a better understanding of the molecular regulatory mechanisms at work in stem cells.
[0003] While gene therapy is still experimental, the technology holds the promise of having a major impact on human health. The scope and definition of gene therapy has changed and expanded over the past few years. In addition to correc...